Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Have a great Sunday, especially those of you like me that are celebrating Orthodox Easter ... As well as those of you who are also like me and mourning another Maple Leafs Game 7 exit ... Ugggh!

Sincerely,

George et al

Message: Re: Question to liahall

May 29, 2013 01:20AM

May 29, 2013 06:20AM

Hi U / Lia,

This was a great concern of mine as well, as the bridging of the two inhalers is what sank the last NDA.

From what I have gathered, thanks to Brentie, is that there are two components from the Affinity 1 study that will bridge the two devices:

1. Pulmonary safety comparisons, as tested by simple spirometry, rather than PFT

2. A1C reduction vs. Lantus arm

- Both the medtone and the dreamboat arm must show HBA1c inferiority to the Lantus / Humalog arm.

Source:

http://seekingalpha.com/article/305499-mannkind-s-ceo-discusses-q3-2011-results-earnings-call-transcript?part=single


May 30, 2013 12:57AM
Share
New Message
Please login to post a reply